Nicole Hogan-Williams is one of several advocates who got a head start on the Pulmonary Hypertension Association’s (PHA’s) Advocacy August campaign by visiting with her elected officials in July. This was Nicole’s first time speaking with congressional offices about the impact of pulmonary hypertension (PH) on her life. She was nervous at first, but

Results from a recent clinical study demonstrated that a cardiac implant system can safely be used in individuals with pulmonary arterial hypertension (PAH), and the device provided useful information to guide health care professionals and their patients to make changes that improved hemodynamics (blood flow). A recently published paper in Chest, a peer-reviewed journal

The session schedule for this year’s PH Professional Network (PHPN) Symposium, “Influencing the Practice: The Art and Science of Treating Pulmonary Hypertension,” being held from Sept. 5-7 in Washington, D.C., has an exceptional lineup of more than 50 respected pulmonary hypertension (PH) experts. Among the highlights of this year’s Symposium is an expert panel

On Friday, July 26, live on Facebook, PHA announced the theme for its PHA 2020 Conference: Vision for a Cure. The PHA International PH Conference and Scientific Sessions will take place in Anaheim, Calif., June 12-14, 2020. The theme was chosen from more than 100 ideas that were submitted by more than 80 individuals

The Arkansas Democrat-Gazette recently featured a story about Thekla McGinley, who leads the PHA Central Arkansas Support Group. In it, she opens up about living with pulmonary hypertension (PH) and what inspired her to start the group. She says, "My disease is progressing, but I'm not stopping. I will never stop. No one needs

Meet Rita Orth. For the past 20 years, Rita has lived with pulmonary hypertension (PH). Along the way, she has sought opportunities to learn how to navigate the challenges of the disease and to find a community with which she could connect. She found both at PHA on the Road. PHA on the Road is

Summary by Bennett Samuel, M.H.A., B.S.N., R.N. Pulmonary hypertension (PH) is a type of high blood pressure. PH affects the blood vessels in the lungs and heart. An atrial septal defect (ASD) is a hole in the wall between the two upper chambers of the heart (atria). PH affects 8-10% of all patients with

On September 5, pulmonary hypertension (PH) medical professionals and other advocates will make their voices heard on Capitol Hill in Washington, D.C., during the Pulmonary Hypertension Association’s PH Professional Network (PHPN) Advocacy Day. “Being on Capitol Hill during the PH Professional Network Advocacy Day was one of the most memorable experiences of my professional

Three copay assistance funds are currently open to help individuals with pulmonary hypertension (PH) pay unreimbursed copays for PH medications. Funding for copays is now available through the PAN Foundation, Patient Advocate Foundation and The Assistance Fund, but these can close at any time when funds have been distributed. PAN Foundation Must be insured

The Pulmonary Hypertension Association (PHA) On The Road Education Forum comes to San Francisco, Calif., on Aug. 10 at The Westin San Francisco Airport. PHA on the Road is a way to bring awareness about PH directly to the area community through interactive sessions presented by local medical experts that help attendees learn more about